1
|
Kang X, Fransen M, Zhang Y, Li H, Ke Y, Lu
M, Su S, Song X, Guo Y, Chen J, et al: The high prevalence of knee
osteoarthritis in a rural Chinese population: The Wuchuan
osteoarthritis study. Arthritis Rheum. 61:641–647. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Zhang Y, Xu L, Nevitt MC, Aliabadi P, Yu
W, Qin M, Lui LY and Felson DT: Comparison of the prevalence of
knee osteoarthritis between the elderly Chinese population in
Beijing and whites in the United States: The Beijing osteoarthritis
study. Arthritis Rheum. 44:2065–2071. 2001. View Article : Google Scholar : PubMed/NCBI
|
3
|
Fernandes JC, Martel-Pelletier J and
Pelletier JP: The role of cytokines in osteoarthritis
pathophysiology. Biorheology. 39:237–246. 2002.PubMed/NCBI
|
4
|
Lotz M: Cytokines in cartilage injury and
repair. Clin Orthop Relat Res. (391 Suppl):S108–S115. 2001.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Goldring MB and Otero M: Inflammation in
osteoarthritis. Curr Opin Rheumatol. 23:471–478. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Wojdasiewicz P and Poniatowski ŁA and
Szukiewicz D: The role of inflammatory and anti-inflammatory
cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm.
2014:ID 561459. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Qu Y, Zhou L and Wang C: Effects of
platycodin D on IL-1β-induced inflammatory response in human
osteoarthritis chondrocytes. Int Immunopharmacol. 40:474–479. 2016.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Mobasheri A: The future of osteoarthritis
therapeutics: Targeted pharmacological therapy. Curr Rheumatol Rep.
15:3642013. View Article : Google Scholar : PubMed/NCBI
|
9
|
He K, Ye X, Wu H, Wang Y, Zou Z, Ning N,
Hu Y, Chen B, Fang X and Li X: The safety and
anti-hypercholesterolemic effect of emodin in Syrian golden
hamsters. Lipids. 50:185–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lin S, Chen H, Wei W, Ye S, Liao W, Gong
J, Jiang Z, Wang L and Lin S: Antiproliferative and antimetastatic
effects of emodin on human pancreatic cancer. Oncol Rep. 26:81–89.
2011.PubMed/NCBI
|
11
|
Gu JW, Hasuo H, Takeya M and Akasu T:
Effects of emodin on synaptic transmission in rat hippocampal CA1
pyramidal neurons in vitro. Neuropharmacology. 49:103–111. 2005.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Meng G, Liu Y, Lou C and Yang H: Emodin
suppresses lipopolysaccharide-induced pro-inflammatory responses
and NF-κB activation by disrupting lipid rafts in CD14-negative
endothelial cells. Br J Pharmacol. 161:1628–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhou PH, Liu SQ and Peng H: The effect of
hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat
model of osteoarthritis. J Orthop Res. 26:1643–1648. 2008.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Chowdhury TT, Bader DL and Lee DA: Dynamic
compression inhibits the synthesis of nitric oxide and PGE(2) by
IL-1beta-stimulated chondrocytes cultured in agarose constructs.
Biochem Biophys Res Commun. 285:1168–1174. 2001. View Article : Google Scholar : PubMed/NCBI
|
15
|
Poole AR, Ionescu M, Fitzcharles MA and
Billinghurst RC: The assessment of cartilage degradation in vivo:
Development of an immunoassay for the measurement in body fluids of
type II collagen cleaved by collagenases. J Immunol Methods.
294:145–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
16
|
Guha M and Mackman N: LPS induction of
gene expression in human monocytes. Cell Signal. 13:85–94. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Corr M: Wnt-beta-catenin signaling in the
pathogenesis of osteoarthritis. Nat Clin Pract Rheumatol.
4:550–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
18
|
Vincenti MP: The matrix metalloproteinase
(MMP) and tissue inhibitor of metalloproteinase (TIMP) genes.
Transcriptional and posttranscriptional regulation, signal
transduction and cell-type-specific expression. Methods Mol Biol.
151:121–148. 2001.
|
19
|
Nagase H and Woessner JF Jr: Matrix
metalloproteinases. J Biol Chem. 274:21491–21494. 1999. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhu X, Zeng K, Qiu Y, Yan F and Lin C:
Therapeutic effect of emodin on collagen-induced arthritis in mice.
Inflammation. 36:1253–1259. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Galasso O, Familiari F, De Gori M and
Gasparini G: Recent findings on the role of gelatinases (matrix
metalloproteinase-2 and −9) in osteoarthritis. Adv Orthop 2012.
Article ID 834208. 2012. View Article : Google Scholar
|
22
|
Wang M, Sampson ER, Jin H, Li J, Ke QH, Im
HJ and Chen D: MMP13 is a critical target gene during the
progression of osteoarthritis. Arthritis Res Ther. 15:R52013.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Vincenti MP and Brinckerhoff CE:
Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in
arthritis: Integration of complex signaling pathways for the
recruitment of gene-specific transcription factors. Arthritis Res.
4:157–164. 2002. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Kobayashi M, Squires GR, Mousa A, Tanzer
M, Zukor DJ, Antoniou J, Feige U and Poole AR: Role of
interleukin-1 and tumor necrosis factor alpha in matrix degradation
of human osteoarthritic cartilage. Arthritis Rheum. 52:128–135.
2005. View Article : Google Scholar : PubMed/NCBI
|
25
|
Ha MK, Song YH, Jeong SJ, Lee HJ, Jung JH,
Kim B, Song HS, Huh JE and Kim SH: Emodin inhibits proinflammatory
responses and inactivates histone deacetylase 1 in hypoxic
rheumatoid synoviocytes. Biol Pharm Bull. 34:1432–1437. 2011.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Hwang JK, Noh EM, Moon SJ, Kim JM, Kwon
KB, Park BH, You YO, Hwang BM, Kim HJ, Kim BS, et al: Emodin
suppresses inflammatory responses and joint destruction in
collagen-induced arthritic mice. Rheumatology (Oxford).
52:1583–1591. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Krens SF, Spaink HP and Snaar-Jagalska BE:
Functions of the MAPK family in vertebrate-development. FEBS Lett.
580:4984–4990. 2006. View Article : Google Scholar : PubMed/NCBI
|